Cerebral venous thrombosis: a rare presentation of paroxysmal nocturnal hemoglobinuria

H. K. Aggarwal, Deepak Jain, Geeta Dabas, R. K. Yadav, Promil Jain


Paroxysmal nocturnal hemoglobinuria (PNH) is a rare type of acquired hemolytic anemia characterized by persistent intravascular hemolysis often associated with pancytopenia and a tendency to venous thrombosis. The classical presentation is passage of hypochromic urine in morning along with hemolytic anemia, bone marrow failure and thrombophilia, but presentation as cerebral venous thrombosis is very rare. Here we present a case of 20 year old female with headache, seizure and hemiparesis, subsequently diagnosed with cerebral venous thrombosis (CVT) due to PNH.


Paroxysmal nocturnal hemoglobinuria, cerebral venous thrombosis

Full Text:



Kumar V, Abbas AK, Fausto N, Mitchell RN. Robbins Basic Pathology. 8th Edition. Philadelphia: Elsevier- Saunders; 2007.

Gulbis B, Eleftheriou A, Angastiniotis M, Ball S, Surralles J, Castella M et al. Epidemiology of rare anemias in Europe. Adv Exp Med Biol 2010; 686:375-96.

Schrezenmeier H, Muus P, Socié G, Szer J, Ispizua A, Maciejewski J et al. Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria Registry. Haematologica 2014; 99:922-9.

Pu JJ, Brodsky RA. Paroxysmal nocturnal hemoglobinuria from bench to bedside. Clin Transl Sci 2011; 4:219-24.

Dacie JV, Lewis SM. Paroxysmal nocturnal haemoglobinuria: clinical manifestations, haematology, and nature of the disease. Ser Haematol 1972; 5:3-23.

Brodsky RA. Paroxysmal nocturnal hemoglobinuria. Blood 2014; 124:2804-11.

van Bijnen STA, Van Heerde WL, Muus P. Mechanisms and clinical implications of thrombosis in paroxysmal nocturnal hemoglobinuria. J Thromb Haemost 2012; 10:1-10.

Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA 2005; 293(13):1653-62.

Parker C, Omine M, Richards S, et al. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood 2005; 106:3699-709.

Hillmen P, Muus P, Duhrsen U, et al. Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria. Blood 2007; 110:4123-8.

DOI: http://dx.doi.org/10.22551/2015.08.0204.10052

Copyright (c) 2015 Archive of Clinical Cases

Creative Commons License
Archive of Clinical Cases is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


ISSN: 2360-6975